Oct 12 (Reuters) - Eureking SA KINGSS.PA :
* EUREKING ANNOUNCES THE ABANDONMENT OF ITS PLANNED
ACQUISITION OF
SKYEPHARMA AND SCTBIO AND THE LAUNCH OF ITS DISSOLUTION THEN
LIQUIDATION PROCESS
* DISCUSSIONS ANNOUNCED ON OCTOBER 9, 2023 TO MODIFY THE
STRUCTURE
OF THE TWO ACQUISITIONS DID NOT REACHED THIS STAGE
* ANNOUNCES THAT IT WILL NOT COMPLETE ITS PROPOSED INITIAL
BUSINESS COMBINATION WITH SKYEPHARMA PRODUCTION SAS AND,
CONSEQUENTLY, ITS PROPOSED ACQUISITION OF SCT CELL MANUFACTURING
S.R.O.
Source text: https://tinyurl.com/yax37s8h
Further company coverage: KINGSS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))